ONIVYDE PEGYLATED LIPOSOMAL 4.3 mg/ml, dispersion for dilution for infusion bottle, 10 ml
Active ingredients: Irinotecan, SEL DE SUCROSOFATE D'IRINOTÉCAN
Commercialized according to BDPMDispensing in France: Prescription only
Dispersion for dilution for infusionbottle, 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml, dispersion à diluer pour perfusion
- Pharmaceutical form
- dispersion à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- LES LABORATOIRES SERVIER
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Apr 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63390752CIP73007415CIP133400930074152Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SEL DE SUCROSOFATE D'IRINOTÉCANdispersion | — | SA |
| IRINOTÉCANdispersion | 4,3 mg · 1 ml de dispersion | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.